Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Leukemia

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    July 2022
  1. KOGAN AA, Topper MJ, Dellomo AJ, Stojanovic L, et al
    Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2022;119:e2123227119.
    PubMed     Abstract available


    June 2022
  2. MIYAKE A, Ngo MH, Wulandari S, Shimojima M, et al
    Convergent evolution of antiviral machinery derived from endogenous retrovirus truncated envelope genes in multiple species.
    Proc Natl Acad Sci U S A. 2022;119:e2114441119.
    PubMed     Abstract available


  3. DONG H, Ham JD, Hu G, Xie G, et al
    Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2022;119:e2122379119.
    PubMed     Abstract available


    April 2022
  4. HOANG DH, Zhao D, Branciamore S, Maestrini D, et al
    MicroRNA networks in FLT3-ITD acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2022;119:e2112482119.
    PubMed     Abstract available


  5. DAI YT, Zhang F, Fang H, Li JF, et al
    Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.
    Proc Natl Acad Sci U S A. 2022;119:e2120787119.
    PubMed     Abstract available


    March 2022
  6. CHAN LH, Yan Q
    Awakening KDM5B to defeat leukemia.
    Proc Natl Acad Sci U S A. 2022;119:e2202245119.
    PubMed    


  7. REN Z, Kim A, Huang YT, Pi WC, et al
    A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    January 2022
  8. PEPE F, Rassenti LZ, Pekarsky Y, Labanowska J, et al
    A large fraction of trisomy 12, 17p(-), and 11q(-) CLL cases carry unidentified microdeletions of miR-15a/16-1.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    December 2021
  9. GUO B, Pomicter AD, Li F, Bhatt S, et al
    Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  10. FERRARO F, Miller CA, Christensen KA, Helton NM, et al
    Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    November 2021
  11. LYCZEK A, Berger BT, Rangwala AM, Paung Y, et al
    Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    October 2021
  12. GARCIA-GARCIA A, Klein T, Born G, Hilpert M, et al
    Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    August 2021
  13. BENSBERG M, Rundquist O, Selimovic A, Lagerwall C, et al
    TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  14. YANG L, Yin J, Wu J, Qiao L, et al
    Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    July 2021
  15. WU A, Zhi J, Tian T, Cihan A, et al
    DOT1L complex regulates transcriptional initiation in human erythroleukemic cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    June 2021
  16. O'SULLIVAN D, Stanczak MA, Villa M, Uhl FM, et al
    Fever supports CD8(+) effector T cell responses by promoting mitochondrial translation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  17. CHRETIEN AS, Devillier R, Granjeaud S, Cordier C, et al
    High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    April 2021
  18. RIVERA OD, Mallory MJ, Quesnel-Vallieres M, Chatrikhi R, et al
    Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  19. OWEN N, Minko IG, Moellmer SA, Cammann SK, et al
    Enhanced cytarabine-induced killing in OGG1-deficient acute myeloid leukemia cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  20. LOVAT F, Gasparini P, Nigita G, Larkin K, et al
    Loss of expression of both miR-15/16 loci in CML transition to blast crisis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  21. HE Y, Pasupala N, Zhi H, Dorjbal B, et al
    NF-kappaB-induced R-loop accumulation and DNA damage select for nucleotide excision repair deficiencies in adult T cell leukemia.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    February 2021
  22. WU K, Huynh KQ, Lu I, Moustakim M, et al
    Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  23. PAN L, Hong C, Chan LN, Xiao G, et al
    PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  24. CHEN L, Zhu HM, Li Y, Liu QF, et al
    Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  25. LEE YL, Ito K, Pi WC, Lin IH, et al
    Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    November 2020
  26. YEH JX, Schultz KLW, Calvert V, Petricoin EF, et al
    The NF-kappaB/leukemia inhibitory factor/STAT3 signaling pathway in antibody-mediated suppression of Sindbis virus replication in neurons.
    Proc Natl Acad Sci U S A. 2020 Nov 3. pii: 2016691117.
    PubMed     Abstract available


    October 2020
  27. BILL M, Mrozek K, Kohlschmidt J, Eisfeld AK, et al
    Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A.
    Proc Natl Acad Sci U S A. 2020 Oct 5. pii: 2014732117.
    PubMed     Abstract available


    September 2020
  28. KRENN PW, Koschmieder S, Fassler R
    Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches.
    Proc Natl Acad Sci U S A. 2020 Sep 14. pii: 2009078117.
    PubMed     Abstract available



  29. Correction for Chen et al., Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia.
    Proc Natl Acad Sci U S A. 2020 Sep 8. pii: 2017617117.
    PubMed    


    August 2020
  30. SEONG D, Jeong M, Seo J, Lee JY, et al
    Identification of MYC as an antinecroptotic protein that stifles RIPK1-RIPK3 complex formation.
    Proc Natl Acad Sci U S A. 2020;117:19982-19993.
    PubMed     Abstract available


  31. JIANG L, Li XP, Dai YT, Chen B, et al
    Multidimensional study of the heterogeneity of leukemia cells in t(8;21) acute myelogenous leukemia identifies the subtype with poor outcome.
    Proc Natl Acad Sci U S A. 2020 Aug 3. pii: 2003900117.
    PubMed     Abstract available


    June 2020
  32. QIAO X, van der Zanden SY, Wander DPA, Borras DM, et al
    Uncoupling DNA damage from chromatin damage to detoxify doxorubicin.
    Proc Natl Acad Sci U S A. 2020;117:15182-15192.
    PubMed     Abstract available


  33. MU L, Kang JH, Olcum S, Payer KR, et al
    Mass measurements during lymphocytic leukemia cell polyploidization decouple cell cycle- and cell size-dependent growth.
    Proc Natl Acad Sci U S A. 2020 Jun 24. pii: 1922197117.
    PubMed     Abstract available


  34. LAMBLE AJ, Kosaka Y, Laderas T, Maffit A, et al
    Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2020 Jun 8. pii: 1916206117.
    PubMed     Abstract available


    May 2020
  35. BRAUN TP, Coblentz C, Smith BM, Coleman DJ, et al
    Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2020 May 29. pii: 1918307117.
    PubMed     Abstract available


  36. LOVAT F, Nigita G, Distefano R, Nakamura T, et al
    Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2020 May 18. pii: 2003597117.
    PubMed     Abstract available


  37. NAGASAKA M, Yamagishi M, Yagishita N, Araya N, et al
    Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Proc Natl Acad Sci U S A. 2020 May 11. pii: 1920346117.
    PubMed     Abstract available


    February 2020
  38. MAITY PC, Bilal M, Koning MT, Young M, et al
    IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling.
    Proc Natl Acad Sci U S A. 2020;117:4320-4327.
    PubMed     Abstract available


    January 2020
  39. KOSLOVA A, Trefil P, Mucksova J, Reinisova M, et al
    Precise CRISPR/Cas9 editing of the NHE1 gene renders chickens resistant to the J subgroup of avian leukosis virus.
    Proc Natl Acad Sci U S A. 2020;117:2108-2112.
    PubMed     Abstract available


    July 2019
  40. KIM JH, Penson AV, Taylor BS, Petrini JHJ, et al
    Nbn-Mre11 interaction is required for tumor suppression and genomic integrity.
    Proc Natl Acad Sci U S A. 2019;116:15178-15183.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: